the magnitude of HbA1c change in this non-diabetic population was modest, as would be expected Fasting insulin levels decreased, indicating improved insulin sensitivity Triglyceride and lipid profiles showed favourable changes, which may reduce cardiometabolic risk Waist circumference was substantially reduced, reflecting a decrease in visceral (abdominal) adiposity These findings are particularly relevant given that excess visceral fat is strongly associated with type 2 diabetes, cardiovascular disease, and metabolic syndrome
Mice were housed under specific pathogen-free (SPF) conditions with ad libitum access to food and water, a controlled temperature (22 2C), and a 12-hour light/dark cycle
The FDA typically requires data from multiple Phase 3 studies covering different populations, doses, and endpoints before accepting a submission
Reviewed by Dietitian Karen Ansel, M.S., RDN Key Points Dietitians say unsweetened plain low-fat kefir is the top high-protein drink for weight loss
10.1152/ajpendo.00030.2002 162
Retatrutide safety profile and current research limits The Retatrutide safety profile is still developing